Anna T. Levy

1.3k total citations
8 papers, 1.2k citations indexed

About

Anna T. Levy is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Anna T. Levy has authored 8 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Anna T. Levy's work include Peptidase Inhibition and Analysis (2 papers), Protease and Inhibitor Mechanisms (2 papers) and Genetic factors in colorectal cancer (2 papers). Anna T. Levy is often cited by papers focused on Peptidase Inhibition and Analysis (2 papers), Protease and Inhibitor Mechanisms (2 papers) and Genetic factors in colorectal cancer (2 papers). Anna T. Levy collaborates with scholars based in United States. Anna T. Levy's co-authors include William G. Stetler‐Stevenson, Lance A. Liotta, Peter de Nully Brown, Inger Margulies, Maurizio Onisto, W. Grigioni, Spiridione Garbisa, Mark E. Sobel, Vittoria Cioce and N S Templeton and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Genomics.

In The Last Decade

Anna T. Levy

7 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anna T. Levy United States	7	820	604	477	277	241	8	1.2k
K Danø Denmark	8	854 1.0×	607 1.0×	425 0.9×	549 2.0×	249 1.0×	8	1.3k
Regina Maki Sasahara Brazil	9	751 0.9×	510 0.8×	701 1.5×	175 0.6×	169 0.7×	10	1.3k
Yves A. De Clerck United States	11	643 0.8×	577 1.0×	370 0.8×	188 0.7×	208 0.9×	14	1.1k
Hiroshi Sato Japan	13	420 0.5×	497 0.8×	284 0.6×	128 0.5×	141 0.6×	15	828
Carlo Hojilla Canada	12	504 0.6×	811 1.3×	732 1.5×	199 0.7×	67 0.3×	19	1.5k
Yiliang E. Liu United States	10	646 0.8×	429 0.7×	343 0.7×	89 0.3×	260 1.1×	11	976
Martin Illemann Denmark	19	478 0.6×	608 1.0×	373 0.8×	137 0.5×	75 0.3×	39	1.2k
M. Eber France	14	356 0.4×	420 0.7×	265 0.6×	160 0.6×	108 0.4×	24	793
Taketoshi Shimada Japan	15	381 0.5×	443 0.7×	313 0.7×	82 0.3×	139 0.6×	40	918
Hyeong-Reh Choi Kim United States	11	344 0.4×	481 0.8×	694 1.5×	119 0.4×	84 0.3×	11	1.3k

Countries citing papers authored by Anna T. Levy

Since Specialization

Citations

This map shows the geographic impact of Anna T. Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna T. Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna T. Levy more than expected).

Fields of papers citing papers by Anna T. Levy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna T. Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna T. Levy. The network helps show where Anna T. Levy may publish in the future.

Co-authorship network of co-authors of Anna T. Levy

This figure shows the co-authorship network connecting the top 25 collaborators of Anna T. Levy. A scholar is included among the top collaborators of Anna T. Levy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna T. Levy. Anna T. Levy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Levy, Anna T., et al.. (2024). Fibroblast growth factor receptor inhibitor-induced hyperphosphatemia: Lessons for the nephrologist. Clinical Nephrology. 103(1). 12–18.

2.

Barta, Valerie S., Nupur N. Uppal, James Pullman, Anna T. Levy, & Kenar D. Jhaveri. (2017). Acute Tubular Injury Associated with Imatinib (Gleevec): A Case Report and Review of the Literature. 1(1). 57–61. 6 indexed citations

3.

Levy, Anna T., et al.. (1992). Cloning and characterization of a novel human cDNA that has DNA similarity to the conserved region of the collagenase gene family. Genomics. 12(1). 175–176. 11 indexed citations

4.

Cohn, Kenneth H., Michael R. Arnold, William B. Solomon, et al.. (1991). Association of nm23-H1 allelic deletions with distant metastases in colorectal carcinoma. The Lancet. 338(8769). 722–724. 117 indexed citations

5.

Levy, Anna T., Vittoria Cioce, Mark E. Sobel, et al.. (1991). Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma.. PubMed. 51(1). 439–44. 265 indexed citations

6.

Brown, Peter de Nully, Anna T. Levy, Inger Margulies, Lance A. Liotta, & William G. Stetler‐Stevenson. (1990). Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines.. PubMed. 50(19). 6184–91. 349 indexed citations

7.

Templeton, N S, Peter de Nully Brown, Anna T. Levy, et al.. (1990). Cloning and characterization of human tumor cell interstitial collagenase.. PubMed. 50(17). 5431–7. 69 indexed citations

8.

Stetler‐Stevenson, William G., Peter de Nully Brown, Maurizio Onisto, Anna T. Levy, & Lance A. Liotta. (1990). Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues.. Journal of Biological Chemistry. 265(23). 13933–13938. 396 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact